US regulatory status: approved. Molecular target: Sodium channel alpha subunit.
- Target
- Sodium channel alpha subunit
- Mechanism
- Sodium channel alpha subunit blocker
pharma · Recurrent Pericarditis · Sjögren’s Disease · KNSA
Kiniksa Pharmaceuticals International
Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International drug portfolio — 7 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
100 Hayden Ave, Lexington, Massachusetts 02421, US HQ
2015 Founded
381 Employees
Public company Type
KNSA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Hayden Ave, Lexington, Massachusetts 02421, US
- Founded
- 2015
- Employees
- 381
- Programs
- 14
- Drugs
- 7
- Patents
- 9
Kiniksa Pharmaceuticals International pipeline
Portfolio lens on 7 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Kiniksa Pharmaceuticals International drug portfolio — 7 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Kiniksa Pharmaceuticals International in public FDA and regional records.
-
covid-19 vaccine (inactivated, adjuvanted, adsorbed)
Antiinfectives for systemic use (J07)Antiinfectives for systemic use (J07) compound in Kiniksa Pharmaceuticals International's portfolio. Mechanism: Biological vaccine - induces immune response.
- Mechanism
- Biological vaccine - induces immune response
-
rilonacept
Antineoplastic and immunomodulating agents (L04)US regulatory status: approved. Molecular target: Interleukin-1 beta.
- Target
- Interleukin-1 beta
- Mechanism
- Interleukin-1 beta inhibitor
-
Development asset linked to Kiniksa Pharmaceuticals International in public FDA and regional records.
-
Development asset linked to Kiniksa Pharmaceuticals International in public FDA and regional records.
-
US regulatory status: approved. Molecular target: Bacterial penicillin-binding protein.
- Target
- Bacterial penicillin-binding protein
- Mechanism
- Bacterial penicillin-binding protein inhibitor